Harrow Health Q1 2024 Adj EPS $(0.28) Misses $(0.20) Estimate, Sales $34.600M Miss $37.268M Estimate
Harrow Health Q1 2024 Adj EPS $(0.28) Misses $(0.20) Estimate, Sales $34.600M Miss $37.268M Estimate
Harrow Health 2024 年第一季度經調整後每股收益 (0.28) 未達到預期 (0.20) 美元，銷售額爲 3,460 萬美元，低於預期 3,7268 萬美元
Harrow Health (NASDAQ:HROW) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.20) by 40 percent. The company reported quarterly sales of $34.600 million which missed the analyst consensus estimate of $37.268 million by 7.16 percent. This is a 32.55 percent increase over sales of $26.103 million the same period last year.
哈羅健康（納斯達克股票代碼：HROW）公佈的季度虧損爲每股0.28美元，比分析師普遍預期的0.20美元（0.20美元）低40％。該公司公佈的季度銷售額爲3,46億美元，比分析師普遍預期的3726.8萬美元低7.16％。這比去年同期的2610.3萬美元的銷售額增長了32.55％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。